
Eric Burton Grimes
Examiner (ID: 7951)
| Most Active Art Unit | 1814 |
| Art Unit(s) | 1652, 1814 |
| Total Applications | 291 |
| Issued Applications | 166 |
| Pending Applications | 38 |
| Abandoned Applications | 87 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 3948113
[patent_doc_number] => 05955343
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/293284
[patent_app_country] => US
[patent_app_date] => 1994-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 25
[patent_no_of_words] => 23319
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955343.pdf
[firstpage_image] =>[orig_patent_app_number] => 293284
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/293284 | Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor | Aug 21, 1994 | Issued |
Array
(
[id] => 3577388
[patent_doc_number] => 05580560
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-03
[patent_title] => 'Modified factor VII/VIIa'
[patent_app_type] => 1
[patent_app_number] => 8/293778
[patent_app_country] => US
[patent_app_date] => 1994-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 9888
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/580/05580560.pdf
[firstpage_image] =>[orig_patent_app_number] => 293778
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/293778 | Modified factor VII/VIIa | Aug 21, 1994 | Issued |
Array
(
[id] => 4033020
[patent_doc_number] => 05856122
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-01-05
[patent_title] => 'Modification of pertussis toxin'
[patent_app_type] => 1
[patent_app_number] => 8/292968
[patent_app_country] => US
[patent_app_date] => 1994-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 17141
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 183
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/856/05856122.pdf
[firstpage_image] =>[orig_patent_app_number] => 292968
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/292968 | Modification of pertussis toxin | Aug 21, 1994 | Issued |
Array
(
[id] => 3857823
[patent_doc_number] => 05792629
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-08-11
[patent_title] => 'Isolated DNA encoding novel protease inhibitory polypeptide'
[patent_app_type] => 1
[patent_app_number] => 8/293150
[patent_app_country] => US
[patent_app_date] => 1994-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 50
[patent_no_of_words] => 36442
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/792/05792629.pdf
[firstpage_image] =>[orig_patent_app_number] => 293150
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/293150 | Isolated DNA encoding novel protease inhibitory polypeptide | Aug 18, 1994 | Issued |
Array
(
[id] => 3591457
[patent_doc_number] => 05585478
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-12-17
[patent_title] => 'D4 gene and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/292945
[patent_app_country] => US
[patent_app_date] => 1994-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 26
[patent_no_of_words] => 10762
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/585/05585478.pdf
[firstpage_image] =>[orig_patent_app_number] => 292945
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/292945 | D4 gene and methods of use thereof | Aug 17, 1994 | Issued |
Array
(
[id] => 3585516
[patent_doc_number] => 05552302
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-09-03
[patent_title] => 'Methods and compositions for production of human recombinant placental ribonuclease inhibitor'
[patent_app_type] => 1
[patent_app_number] => 8/282151
[patent_app_country] => US
[patent_app_date] => 1994-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 6713
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/552/05552302.pdf
[firstpage_image] =>[orig_patent_app_number] => 282151
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/282151 | Methods and compositions for production of human recombinant placental ribonuclease inhibitor | Jul 26, 1994 | Issued |
Array
(
[id] => 3586740
[patent_doc_number] => 05550037
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-08-27
[patent_title] => 'Mammalian augmenter of liver regeneration (ALR): human and rat'
[patent_app_type] => 1
[patent_app_number] => 8/275370
[patent_app_country] => US
[patent_app_date] => 1994-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 21
[patent_no_of_words] => 10798
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/550/05550037.pdf
[firstpage_image] =>[orig_patent_app_number] => 275370
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/275370 | Mammalian augmenter of liver regeneration (ALR): human and rat | Jul 14, 1994 | Issued |
Array
(
[id] => 3695509
[patent_doc_number] => 05661126
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-08-26
[patent_title] => 'Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression'
[patent_app_type] => 1
[patent_app_number] => 8/271252
[patent_app_country] => US
[patent_app_date] => 1994-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 36
[patent_no_of_words] => 43019
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/661/05661126.pdf
[firstpage_image] =>[orig_patent_app_number] => 271252
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/271252 | Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression | Jul 6, 1994 | Issued |
Array
(
[id] => 3633121
[patent_doc_number] => 05631156
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-05-20
[patent_title] => 'DNA encoding and 18 KD CDK6 inhibiting protein'
[patent_app_type] => 1
[patent_app_number] => 8/263935
[patent_app_country] => US
[patent_app_date] => 1994-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7173
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/631/05631156.pdf
[firstpage_image] =>[orig_patent_app_number] => 263935
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/263935 | DNA encoding and 18 KD CDK6 inhibiting protein | Jun 20, 1994 | Issued |
Array
(
[id] => 3418957
[patent_doc_number] => 05478742
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1995-12-26
[patent_title] => 'Alkaline proteases from Bacillus pumilus'
[patent_app_type] => 1
[patent_app_number] => 8/260997
[patent_app_country] => US
[patent_app_date] => 1994-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7169
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/478/05478742.pdf
[firstpage_image] =>[orig_patent_app_number] => 260997
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/260997 | Alkaline proteases from Bacillus pumilus | Jun 15, 1994 | Issued |
Array
(
[id] => 3850472
[patent_doc_number] => 05767073
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-16
[patent_title] => 'D4 gene and methods of use thereof'
[patent_app_type] => 1
[patent_app_number] => 8/252073
[patent_app_country] => US
[patent_app_date] => 1994-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 31
[patent_no_of_words] => 14482
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/767/05767073.pdf
[firstpage_image] =>[orig_patent_app_number] => 252073
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/252073 | D4 gene and methods of use thereof | May 31, 1994 | Issued |
| 08/251121 | MODIFICATION OF PERTUSSIS TOXIN | May 30, 1994 | Abandoned |
Array
(
[id] => 3791221
[patent_doc_number] => 05726051
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-03-10
[patent_title] => 'Transglutaminase gene'
[patent_app_type] => 1
[patent_app_number] => 8/247902
[patent_app_country] => US
[patent_app_date] => 1994-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8259
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/726/05726051.pdf
[firstpage_image] =>[orig_patent_app_number] => 247902
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/247902 | Transglutaminase gene | May 22, 1994 | Issued |
| 08/243403 | GENE CODING FOR A PROTEIN REGULATING AUREOBASIDIN SENSITIVITY | May 15, 1994 | Abandoned |
Array
(
[id] => 3525638
[patent_doc_number] => 05541112
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-07-30
[patent_title] => 'Genes which influence pichia proteolytic activity, and uses therefor'
[patent_app_type] => 1
[patent_app_number] => 8/245756
[patent_app_country] => US
[patent_app_date] => 1994-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 20240
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/541/05541112.pdf
[firstpage_image] =>[orig_patent_app_number] => 245756
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/245756 | Genes which influence pichia proteolytic activity, and uses therefor | May 15, 1994 | Issued |
Array
(
[id] => 3722238
[patent_doc_number] => 05672491
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1997-09-30
[patent_title] => 'Recombinant production of novel polyketides'
[patent_app_type] => 1
[patent_app_number] => 8/238811
[patent_app_country] => US
[patent_app_date] => 1994-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 15
[patent_no_of_words] => 14538
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/672/05672491.pdf
[firstpage_image] =>[orig_patent_app_number] => 238811
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/238811 | Recombinant production of novel polyketides | May 5, 1994 | Issued |
| 08/239430 | BIOTIN BIOSYNTHESIS IN BACILLUS SUBTILIS | May 5, 1994 | Abandoned |
Array
(
[id] => 3521679
[patent_doc_number] => 05489528
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-02-06
[patent_title] => 'Recombinant core-streptavidin'
[patent_app_type] => 1
[patent_app_number] => 8/211833
[patent_app_country] => US
[patent_app_date] => 1994-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4068
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/489/05489528.pdf
[firstpage_image] =>[orig_patent_app_number] => 211833
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/211833 | Recombinant core-streptavidin | Apr 27, 1994 | Issued |
Array
(
[id] => 3869371
[patent_doc_number] => 05763271
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1998-06-09
[patent_title] => 'Vasodilatory and immune suppressant peptides'
[patent_app_type] => 1
[patent_app_number] => 8/233597
[patent_app_country] => US
[patent_app_date] => 1994-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9639
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/763/05763271.pdf
[firstpage_image] =>[orig_patent_app_number] => 233597
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/233597 | Vasodilatory and immune suppressant peptides | Apr 25, 1994 | Issued |
Array
(
[id] => 3566404
[patent_doc_number] => 05484725
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1996-01-16
[patent_title] => 'Norbornane type ester hydrolase from Acetobacter pasteurianus'
[patent_app_type] => 1
[patent_app_number] => 8/232519
[patent_app_country] => US
[patent_app_date] => 1994-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7801
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/484/05484725.pdf
[firstpage_image] =>[orig_patent_app_number] => 232519
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/232519 | Norbornane type ester hydrolase from Acetobacter pasteurianus | Apr 21, 1994 | Issued |